The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse

Obul Reddy Bandapalli(German Cancer Research Center), A. E. Kulozik(European Molecular Biology Organization), M. Stanulla(Medizinische Hochschule Hannover), Martin Schrappe(University Hospital Schleswig-Holstein), Shai Izraeli(Tel Aviv University), Viktoras Frismantas, Nava Gershman(Tel Aviv University), Rupert Handgretinger(STZ eyetrial), Jana Hof(German Cancer Research Center), Tobias Rausch, Rolf Koehler(Novartis (Switzerland)), Joachim B. Kunz(Heidelberg University), S. Avigad(Schneider Children's Medical Center), Renate Kirschner‐Schwabe(Charité - Universitätsmedizin Berlin), Ifat Geron(Tel Aviv University), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Martina U. Muckenthaler(Heidelberg University), Jan O. Korbel(European Bioinformatics Institute), Noam Tal-Perry(Tel Aviv University), S. Schuessele(European Molecular Biology Organization), Adrian M. Stütz(Winterthur Museum Garden and Library), June Eilers(Fred Hutch Cancer Center), M Zimmermann(Medizinische Hochschule Hannover), Beat Bornhäuser(University Children's Hospital Zurich), A von Stackelberg(Royal London Hospital), Nina Vaezipour(European Molecular Biology Organization)
Haematologica
June 27, 2014
Cited by 122


Related Papers